Whalegun
Home

Gwenn Hansen, Chief Scientific Officer: Nurix Therapeutics NRIX Sell · Filed 24/01/30

Trade details

Type
Insider sale
Amount
$18,648.66
Shares · price
2,334 sh · $7.99 a share
Held after
36,402 sh
Stock
Nurix Therapeutics NRIX
Person
Gwenn HansenChief Scientific Officer
Trade date
24/01/30
Filed
24/01/30
Days to filing
0 days

Sold 6.0% of holdings

Share of holding sold
6.0%

Nurix Therapeutics trades, last 26 weeks

What else happened in Nurix Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/31~24/02/29

Gwenn Hansen's recent trades

  • Gwenn Hansen

    Planned sale10b5-1 planNurix Therapeutics

    $215.1K

    Filed 08/05

  • Gwenn Hansen

    Planned sale10b5-1 planNurix Therapeutics

    $95.5K

    Filed 08/04

  • Gwenn Hansen

    Sell10b5-1 planNurix Therapeutics

    $107.9K

    Filed 06/25

  • Gwenn Hansen

    Planned sale10b5-1 planNurix Therapeutics

    $104.1K

    Filed 06/25

  • Gwenn Hansen

    SellNurix Therapeutics

    $53.5K

    Filed 04/30